Product Information
IMATINIB MESYLATE 400 MG TAB is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $2.9484 per EA under NDC 00832053303. Its NADAC has been published 90 times since Oct 9, 2024.
Strength
400 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832053303
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA212135On Market Since
5/17/2024
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 400 MG TAB has been published 90 times since Oct 9, 2024, and over the history we have for it it has risen 42.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9484 per EA |
|---|---|
| All-time high | $3.2150 (Mar 11, 2026) |
| All-time low | $2.0729 (Oct 9, 2024) |
| 52-week high | $3.2150 |
| 52-week low | $2.6631 |
| Median price | $2.8673 |
| Average price | $2.8435 |
| Largest weekly change | +24.0% (Oct 23, 2024) |
| Weeks tracked | 90 |
| Tracking since | Oct 9, 2024 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 400 MG TAB, manufactured by Upsher-Smith Laboratories LLC, is $2.9484 per EA (NDC 00832053303), effective Jun 24, 2026.
How has the price of IMATINIB MESYLATE 400 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 400 MG TAB has risen 42.2%. It has been tracked across 90 weekly CMS publications since Oct 9, 2024.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 400 MG TAB?
Since Oct 9, 2024, the NADAC for IMATINIB MESYLATE 400 MG TAB has ranged from a low of $2.0729 (Oct 9, 2024) to a high of $3.2150 (Mar 11, 2026), with a median of $2.8673 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 400 MG TAB?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IMATINIB MESYLATE 400 MG TAB, is $2.0356 per EA — about 31% below IMATINIB MESYLATE 400 MG TAB.
Who manufactures IMATINIB MESYLATE 400 MG TAB?
IMATINIB MESYLATE 400 MG TAB (NDC 00832053303) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification